Healthcare merger and acquisition (M&A) activity in the fourth quarter of 2020 exceeded $8.3 billion in disclosed transaction value across 524 deals in Canada and the US. The average deal size among disclosed transactions was$15.9 million, a slight decline from $18.2 million in the third quarter of 2020. In Canada, the top Healthcare sub-sectors for deal activity in the quarter were pharmaceuticals (16), healthcare technology (13), healthcare services (11)and drug retail (9). Together, these sub-sectors accounted for over 77% of Canadian Healthcare deal volume. In2020, industry EV/EBITDA multiples (based on private equity transactions listed below) increased 27% from the previous year and averaged a multiple of 7.1x for lower mid-market transaction values (10 – 25 million range).
Insights
-
Confidence
August 22, 2025
Is your financial entity prepared for FINTRAC’s anti-money laundering (AML) compliance crackdown?
Is your financial entity ready for an examination from FINTRAC? Discover where financial entities are falling short and strengthen your AML program.
-
Progress
August 21, 2025
How to make the most of your clinic or practice valuation
Find out what you need to know to understand, read, and improve the valuation of your clinic or practice with this guide designed especially for professionals.
-
Confidence
August 21, 2025
Beyond green: Cleantech as a business strategy in Canada
How will cleantech impact your business? Leveraging the right technologies and federal support can help your business drive growth and stay competitive.
